Profile picture for Sheila Reyes, MD

Sheila Reyes, MD

Sheila Reyes, MD, is a Consultant Rheumatologist and member of the Rheumatology Fellowship Training Committee at the St. Luke’s Medical Center – Quezon City, Philippines. She is a sub-investigator in clinical trials for SLE and spondyloarthritis. She is a regular faculty in various educational activities of Philippine Rheumatology Association in partnership with Rheumatology Educational Trust Foundation, Inc (RETFI) which conducts workshops on musculoskeletal exam and lectures on lupus in alliance with other disciplines. Her other areas of interest include myositis, systemic sclerosis and vasculitis. Follow her on Twitter at @RHEUMarampa. 

Articles By Sheila Reyes, MD

vial,syringe,vaccine

Vaccination Strategies in Autoimmune and Inflammatory Diseases

By Sheila Reyes, MD

Infection remains an important threat to patients with autoimmune and inflammatory diseases. Mitigating this risk is a core duty of the rheumatologist—one that requires us to actively educate patients and advocate for timely vaccination strategies. This article reviews important highlights on the session, “Prevention and treatment of Infections in rheumatic diseases” during the APLAR 2026 Congress.

Read Article
Preg2_0.jpg

Pregnancy in Lupus Nephritis and RA: Managing risks and treating to target

By Sheila Reyes, MD

A significant proportion of patients with rheumatologic disease are of reproductive age, therefore, navigating reproductive health is now widely recognized as a fundamental component of modern rheumatology care. 

Read Article
EULAR meeting room

Imaging in SpA: are we seeing a clearer picture?

By Sheila Reyes, MD

As EULAR2026 comes to a close, practical learnings take precedence as clinicians head back to their clinics. Among them, the 2026 EULAR Update on Imaging Recommendations in SpA stands out.

Read Article
pill pillbox adherence

Lessons on Non-adherence

By Sheila Reyes, MD

Dr. Sun et al. from Duke University presented abstract POS0692 during one of the poster sessions entitled, “Lupus patients with concurrent inflammatory activity and symptom burdens have the lowest medication adherence and experience distinct adherence barriers.” They evaluated differences in self-reported medication adherence and reasons for nonadherence across Type 1 & 2 SLE classification groups, with a prespecified focus on comparing the Mixed Activity group to all other groups.

Read Article
MRI.scan

MRI as a novel biomarker in lupus

By Sheila Reyes, MD

The clinical abstract sessions on diagnostic tools in lupus showcased interesting studies, including the use of MRI as potential non-invasive biomarkers.

Read Article
DPGN, lupus, nephritis, GN, glomerulonephritis, biopsy, kidney

Tacrolimus in Lupus Nephritis Management

By Sheila Reyes, MD

Prof. Sandra Navarra and colleagues compared the efficacy and safety of tacrolimus and glucocorticoids vs. mycophenolate mofetil (MMF) as a continuous induction-maintenance treatment for class III/IV+V lupus nephritis.

Read Article
lupus SLE

The Decade Ahead: Predicting Long-Term Proteinuria Risk in SLE

By Sheila Reyes, MD

The ACR Convergence 2025 in Chicago opens with engaging topics curated for the global rheumatologist. As a clinician, I always look forward to sessions that provide updates and practical key points that I can bring home and apply to my practice.

Read Article
Target

Hitting the Target: T2T Therapy in SLE

By Sheila Reyes, MD

Treat-to-target strategies are not a new concept in rheumatology. It has shown to improve patient outcomes and quality of life in RA and PsA, and is now being increasingly adopted not only in SLE research but also in clinical practice. This article reviews key highlights from Dr. Eric Morand’s plenary session lecture on Treat to Target in SLE: Current Evidence and Future Directions, presented during the recent APLAR 2025 Congress.

Read Article
APLAR GRAY

SLE and Osteoporosis

By Sheila Reyes, MD

In one of the SLE sessions at the APLAR 2025 Congress, Prof. Sandra Navarra discussed the assessment and management of osteoporosis in SLE patients, particularly glucocorticoid-induced osteoporosis (GIOP) and this article reviews the highlights and key takeaways from her talk.

Read Article
pregnant woman

ICYMI: Reproductive Issues in axSpA: Fertility and Pregnancy

By Sheila Reyes, MD

Axial spondyloarthritis (axSpA) affects young patients with symptom onset occurring in early adulthood. Apart from pain and quality of life, reproductive issues also arise because patients who are diagnosed with the disease are also in their reproductive age. Two interesting abstracts about reproductive issues in axSpA will be presented during the poster sessions on Saturday, November 16, 2024.

Read Article
×